Source comparison
CJC-1295 No DAC vs Other Peptides: Recovery Comparison
CJC-1295 no DAC 30 minutes 7–10 days 12–14 days 14 Pituitary sensitization persists despite rapid peptide clearance Ipamorelin 2 hours 3–5 days 7–9 days 10 Fastest recovery among growth hormone secretagogues GHRP-6 20 minutes 5–7 days 10–12 days 12 Ghrelin rec
This comparison does not assign a generated winner or score.
- CJC-1295 no DAC
- 30 minutes
- 7–10 days
- 12–14 days
- 14
- Pituitary sensitization persists despite rapid peptide clearance
- Ipamorelin
- 2 hours
- 3–5 days
- 7–9 days
- 10
- Fastest recovery among growth hormone secretagogues
- GHRP-6
- 20 minutes
- 5–7 days
- 10–12 days
- 12
- Ghrelin receptor activation extends metabolic effects
- CJC-1295 DAC
- 6–8 days
- 21–28 days
- 28–35 days
- 35
- Drug Affinity Complex modification dramatically extends all timelines
- Hexarelin
- 70 minutes
- 10–14 days
- 14–18 days
- 18
- Highest receptor desensitization risk. Longer recovery required
- CJC-1295 no DAC sits in the middle of the recovery spectrum. It clears faster than DAC-modified versions but slower than ipamorelin. Researchers selecting peptides for time-sensitive studies should account for these windows upfront. A 12-week study with three sequential peptide phases needs 42 days of washout time built into the timeline, not zero.